Cite
MLA Citation
S Usmani et al.. “P14: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA.” HemaSphere, vol. 6, n.d., p. 19. http://access.bl.uk/ark:/81055/vdc_100153435583.0x00001f